Financials data is unavailable for this security.
View more
Year on year Resmed Inc grew revenues 10.95% from 4.22bn to 4.69bn while net income improved 13.75% from 897.56m to 1.02bn.
Gross margin | 57.67% |
---|---|
Net profit margin | 23.15% |
Operating margin | 29.50% |
Return on assets | 15.94% |
---|---|
Return on equity | 23.56% |
Return on investment | 18.11% |
More ▼
Cash flow in USDView more
In 2024, Resmed Inc did not generate a significant amount of cash. However, the company earned 1.40bn from its operations for a Cash Flow Margin of 29.91%. In addition the company used 269.78m on investing activities and also paid 1.12bn in financing cash flows.
Cash flow per share | 8.74 |
---|---|
Price/Cash flow per share | 28.73 |
Book value per share | 35.39 |
---|---|
Tangible book value per share | 12.47 |
More ▼
Balance sheet in USDView more
Current ratio | 2.92 |
---|---|
Quick ratio | 1.91 |
Total debt/total equity | 0.1304 |
---|---|
Total debt/total capital | 0.1154 |
More ▼
Growth rates in USD
SmartText is unavailable
Div yield(5 year avg) | 0.80% |
---|---|
Div growth rate (5 year) | 5.34% |
Payout ratio (TTM) | 26.02% |
EPS growth(5 years) | 19.48 |
---|---|
EPS (TTM) vs TTM 1 year ago | 22.72 |
More ▼